| Product Code: ETC5298961 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Parenteral Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Parenteral Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Parenteral Drugs Market - Industry Life Cycle |
3.4 Sweden Parenteral Drugs Market - Porter's Five Forces |
3.5 Sweden Parenteral Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Sweden Parenteral Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Parenteral Drugs Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.8 Sweden Parenteral Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Parenteral Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Parenteral Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of chronic diseases in Sweden leading to increased demand for parenteral drugs. |
4.2.2 Technological advancements in drug delivery systems improving the efficacy and safety of parenteral drugs. |
4.2.3 Increasing healthcare expenditure by the Swedish government to enhance healthcare infrastructure and services. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of parenteral drugs leading to longer time-to-market. |
4.3.2 High cost associated with parenteral drug development and production impacting market accessibility. |
4.3.3 Limited availability of skilled healthcare professionals for administering parenteral drugs. |
5 Sweden Parenteral Drugs Market Trends |
6 Sweden Parenteral Drugs Market Segmentations |
6.1 Sweden Parenteral Drugs Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Parenteral Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.1.3 Sweden Parenteral Drugs Market Revenues & Volume, By Immunoglobulin, 2021-2031F |
6.1.4 Sweden Parenteral Drugs Market Revenues & Volume, By Cytokines, 2021-2031F |
6.1.5 Sweden Parenteral Drugs Market Revenues & Volume, By Insulin, 2021-2031F |
6.1.6 Sweden Parenteral Drugs Market Revenues & Volume, By Peptide Hormones, 2021-2031F |
6.1.7 Sweden Parenteral Drugs Market Revenues & Volume, By Blood Factors, 2021-2031F |
6.1.9 Sweden Parenteral Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Sweden Parenteral Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Sweden Parenteral Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Parenteral Drugs Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 Sweden Parenteral Drugs Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.2.4 Sweden Parenteral Drugs Market Revenues & Volume, By Diabetes, 2021-2031F |
6.2.5 Sweden Parenteral Drugs Market Revenues & Volume, By Blood disorders, 2021-2031F |
6.2.6 Sweden Parenteral Drugs Market Revenues & Volume, By Hormonal Disorders, 2021-2031F |
6.2.7 Sweden Parenteral Drugs Market Revenues & Volume, By Musculoskeletal Disorders, 2021-2031F |
6.2.8 Sweden Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021-2031F |
6.2.9 Sweden Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021-2031F |
6.3 Sweden Parenteral Drugs Market, By Molecule Type |
6.3.1 Overview and Analysis |
6.3.2 Sweden Parenteral Drugs Market Revenues & Volume, By Small Molecules, 2021-2031F |
6.3.3 Sweden Parenteral Drugs Market Revenues & Volume, By Large Molecules, 2021-2031F |
6.4 Sweden Parenteral Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Parenteral Drugs Market Revenues & Volume, By Intravenous (IV), 2021-2031F |
6.4.3 Sweden Parenteral Drugs Market Revenues & Volume, By Intramuscular (IM), 2021-2031F |
6.4.4 Sweden Parenteral Drugs Market Revenues & Volume, By Subcutaneous (SC), 2021-2031F |
6.5 Sweden Parenteral Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Parenteral Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.5.3 Sweden Parenteral Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.5.4 Sweden Parenteral Drugs Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.5.5 Sweden Parenteral Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Sweden Parenteral Drugs Market Import-Export Trade Statistics |
7.1 Sweden Parenteral Drugs Market Export to Major Countries |
7.2 Sweden Parenteral Drugs Market Imports from Major Countries |
8 Sweden Parenteral Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for parenteral drugs conducted in Sweden. |
8.2 Rate of adoption of innovative drug delivery technologies in the parenteral drugs market. |
8.3 Percentage of healthcare facilities equipped with necessary infrastructure for parenteral drug administration. |
9 Sweden Parenteral Drugs Market - Opportunity Assessment |
9.1 Sweden Parenteral Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Sweden Parenteral Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Parenteral Drugs Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.4 Sweden Parenteral Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Parenteral Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Parenteral Drugs Market - Competitive Landscape |
10.1 Sweden Parenteral Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Parenteral Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here